Zobrazeno 1 - 10
of 701
pro vyhledávání: '"S. Todesco"'
Publikováno v:
Reumatismo, Vol 59, Iss 1s, Pp 52-55 (2011)
Psoriatic arthritis (PsA) has been classically defined as an inflammatory arthritis associated with psoriasis. However, in comparison with other relevant inflammatory arthropathies, in which a definite diagnosis is frequently possible only by means o
Externí odkaz:
https://doaj.org/article/8e0fe5c03f724a1793aae3794c1a5bf3
Autor:
L. Punzi, U. Fiocco, C. Botsios, M. Podswiadek, P. Grypiotis, A. Ruffatti, A. Hoxha, S. Todesco
Publikováno v:
Reumatismo, Vol 58, Iss 2, Pp 121-126 (2011)
Objective: We evaluated the induction and clinical significance of ANA, anti-dsDNA and anti-ENA during infliximab therapy in patients with Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS). Methods: We tested sera from 30 RA and 30 AS patients
Externí odkaz:
https://doaj.org/article/a787cf4a7c534ea1a320c84621ac9d04
Publikováno v:
Reumatismo, Vol 60, Iss 2, Pp 77-84 (2011)
Le principali artriti croniche ad eziopatogenesi immunoflogistica, nelle quali trovano applicazione i farmaci “biologici” (v. oltre) sono la reumatoide e le sieronegative: artrite psoriasica, spondilite anchilosante, artriti reattive ed artriti
Externí odkaz:
https://doaj.org/article/f18e7d56fd7c41808986ca9a9b913197
Publikováno v:
Reumatismo, Vol 56, Iss 1s, Pp 62-73 (2011)
Interleukin 1 receptor antagonist (IL-1Ra) is a naturally occurring IL-1 inhibitor, acting as a “receptor antagonist”, which blocks IL-1 mediated signal transduction. In 1990 IL-1Ra was cloned and later on, a large numbers of studies led to discl
Externí odkaz:
https://doaj.org/article/077d13aa737f4b3eab3ebae421b40a53
Publikováno v:
Reumatismo, Vol 59, Iss 1, Pp 32-37 (2011)
Objective: We evaluated both the efficacy and safety of anakinra in daily routine rheumatoid arthritis clinical practice. Methods:We studied 60 cases, including patients with previous anti-TNFα exposure, treated with anakinra (100 mg/daily s.c.) in
Externí odkaz:
https://doaj.org/article/5d0e3d11f15e4cd88cdf87bb19fe026f
Publikováno v:
Reumatismo, Vol 57, Iss 3, Pp 197-200 (2011)
Arthritis and tenosynovitis are frequently reported as complications of inflammatory bowel diseases. About 10% of patients with ulcerative colitis presents articular inflammation, usually in the phases of activity of intestinal disease. Tenosynovitis
Externí odkaz:
https://doaj.org/article/76e244116eed4742950c1426ef93508e
Autor:
S. Todesco, T. Del Ross, A. Calligaro, M. Tonello, M. Favaro, O. Milanesi, A. Ruffatti, C. Grava
Publikováno v:
Reumatismo, Vol 57, Iss 3, Pp 180-186 (2011)
Objective: To study the incidence and the features of congenital heart block (CHB) in patients with undifferentiated connective tissue disease (UCTD) and primary Sjögren’s syndrome (pSS). Methods: We studied 81 pregnancies of 41 women attending th
Externí odkaz:
https://doaj.org/article/2fa50414b6c8494a96211b2193fe05ab
Publikováno v:
Reumatismo, Vol 57, Iss 1, Pp 44-51 (2011)
Objective: We report the incidence and treatment of infusion reactions to infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor a, in a large cohort of patients with rheumatoid arthritis. Patients and methods: One hundred eigh
Externí odkaz:
https://doaj.org/article/0892cc15a61c44c4bb12f95dcd4b2c5e
Autor:
C. Giacometti, L. Rubaltelli, A. Di Maggio, R. Nardacchione, C. Botsios, L. Cozzi, M. Vezzù, E. Pagnin, E. Scagliori, F. Sovran, F. Oliviero, P. Sfriso, U. Fiocco, F. Calabrese, S. Todesco
Publikováno v:
Reumatismo, Vol 58, Iss 4, Pp 268-274 (2011)
Pigmented villonodular synovitis (PVNS) is a rare pre-malignant disease that require aggressive treatment as surgical synovectomy, eventually followed by radiosynovectomy. Nevertheless, the disease often reoccurs after these treatments. To determine
Externí odkaz:
https://doaj.org/article/c2322c72342b4197a9ad74239a677ff6
Autor:
M. Ciprian, M. Favaro, A. Calligaro, G. Salmistraro, M. Tonello, A. Ruffatti, T. Del Ross, S. Todesco
Publikováno v:
Reumatismo, Vol 58, Iss 4, Pp 283-287 (2011)
Objective. In order to investigate the potential role of hyperhomocysteinemia as an additional risk factor for thrombotic events, we studied its prevalence in patients with primary antiphospholipid syndrome (APS) and evaluated its association with di
Externí odkaz:
https://doaj.org/article/e6c7ed8e9e72492ca6f52ac19d605b65